Vertex Newsroom

Vertex Gets Expanded FDA Approval for Cystic Fibrosis Treatment

WSJDec 21 05:00

Vertex Announces US FDA Approval of ALYFTREK, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

BusinesswireDec 21 04:46

Vertex Announces U.S. FDA Approval for TRIKAFTA (Elexacaftor/tezacaftor/ivacaftor and Ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

BusinesswireDec 21 04:35

Vertex (VERX.US) non-addictive painkillers encounter the "placebo effect" which analysts say brings setbacks.

Vertex Pharmaceuticals' non-addictive medication has helped patients relieve back pain in mid-term trials, but the effectiveness is not much better than that of a placebo.

Zhitong FinanceDec 19 21:29

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

BusinesswireDec 19 19:00

Vertex Insider Sold Shares Worth $1,060,932, According to a Recent SEC Filing

MT NewswiresDec 19 05:17

Stifel Maintains Vertex(VERX.US) With Buy Rating, Raises Target Price to $58

Futu NewsDec 19 04:31 · Ratings

Vertex Is Maintained at Buy by Stifel

Dow JonesDec 19 01:36 · Ratings

Express News | Vertex Inc : Stifel Raises Target Price to $58 From $52

BreakingsDec 18 20:42

4 Big Drug Stocks That May Continue to Outperform in 2025

Zacks Dec 17 22:30

Vertex Is Maintained at Neutral by Citigroup

Dow JonesDec 17 00:12 · Ratings

Vertex Named a Leader in the 2024 IDC MarketScape for Worldwide SaaS and Cloud-Enabled Tax Automation Software for Enterprise, SMB and VAT

GlobeNewswireDec 16 23:44

Citi Maintains Vertex(VERX.US) With Hold Rating, Raises Target Price to $54

Futu NewsDec 16 20:31 · Ratings

Express News | Vertex Inc : Citigroup Raises Target Price to $54 From $46

BreakingsDec 16 19:21

Vertex(VERX.US) Officer Sells US$20.97 Million in Common Stock

$Vertex(VERX.US)$ Officer DeStefano David sold 381.1K shares of common stock on Dec 10, 11, 2024 at an average price of $55.038 for a total value of $20.97 million.Source: Announcement What is

Futu NewsDec 13 07:17

Vertex(VERX.US) 10% Shareholder Sells US$4.13 Million in Common Stock

$Vertex(VERX.US)$ 10% Shareholder ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL dated October 5, 2001 sold 75,000 shares of common stock on Dec 9, 10, 2024 at an average

Futu NewsDec 12 07:06

Decoding 9 Analyst Evaluations For Vertex

BenzingaDec 10 02:00

Vertex Price Target Maintained With a $61.00/Share by JMP Securities

Dow JonesDec 10 00:27 · Ratings

Vertex Analyst Ratings

BenzingaDec 10 00:14 · Ratings

JMP Securities Maintains Vertex(VERX.US) With Buy Rating, Maintains Target Price $61

Futu NewsDec 9 14:31 · Ratings